New arthritis drug enters first human safety testing
NCT ID NCT06902519
Summary
This early-stage study aims to test the safety and side effects of a new drug called GS-0151 in adults with rheumatoid arthritis. Researchers will give different doses to 75 participants to see how their bodies handle the medication and monitor for any problems. The study will also measure how long the drug stays in the body and check if it helps reduce arthritis symptoms in some participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ARENSIA Exploratory Medicine, LLC
RECRUITINGTbilisi, 0112, Georgia
-
Accurate Clinical Management, LLC
RECRUITINGBaytown, Texas, 77521, United States
-
Accurate Clinical Research, Inc
RECRUITINGLake Charles, Louisiana, 70605, United States
-
Accurate Clinical Research, Inc
RECRUITINGHouston, Texas, 77089, United States
-
Altoona Center for Clinical Research
RECRUITINGDuncansville, Pennsylvania, 16635, United States
-
Clinical Research of West Florida, Inc
RECRUITINGClearwater, Florida, 33765, United States
-
Clinical Trials of Texas LLC, dba Flourish Research
RECRUITINGSan Antonio, Texas, 78229, United States
-
Clinicmed Daniluk
RECRUITINGBialystok, 15-879, Poland
-
Complejo Hospitalario Universitario A Coruna
RECRUITINGA Coruña, 15006, Spain
-
DM Clinical Research
RECRUITINGMelrose Park, Illinois, 60160, United States
-
FutureMeds Gydinia
RECRUITINGGdynia, 81-384, Poland
-
FutureMeds Lodz
RECRUITINGLodz, 91-363, Poland
-
FutureMeds Targowek
RECRUITINGWarszawa Targówek, 03-291, Poland
-
FutureMeds Wroclaw
RECRUITINGWroclaw, 53-673, Poland
-
Great Lakes Clinical Trials dba Flourish Research Chicago
RECRUITINGChicago, Illinois, 60640, United States
-
Hamburger Rheuma Forschungszentrum II
RECRUITINGHamburg, 20095, Germany
-
Hospital Quironsalud Infanta Luisa
RECRUITINGSeville, 41010, Spain
-
Hospital Universitari Parc Tauli
RECRUITINGSabadell, 08208, Spain
-
Hospital Universitario Ramon y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital del Mar
RECRUITINGBarcelona, 8003, Spain
-
Klinikum der Universitat Munchen
RECRUITINGMünchen, 81377, Germany
-
Krakenhaus Porz am Rhein
RECRUITINGCologne, 51149, Germany
-
Lynn Health Science Institute
RECRUITINGOklahoma City, Oklahoma, 73112, United States
-
MICS Centrum Medyczne Torun
RECRUITINGTorun, 87-100, Poland
-
Medvin Clinical Research
RECRUITINGTujunga, California, 91042, United States
-
Medvin Clinical Research
RECRUITINGWhittier, California, 90602, United States
-
Pinnacle Research Group, LLC
RECRUITINGAnniston, Alabama, 36207, United States
-
Republican Clinical Hospital "Timofei Mosneaga," Arensia EM
RECRUITINGChisinau, MD-2025, Moldova
-
Stanford University School of Medicine
RECRUITINGPalo Alto, California, 94304, United States
-
Tidewater Clinical Research, LLC/ Virginia Rheumatology Clinic
RECRUITINGVirginia Beach, Virginia, 23456, United States
-
Universitatsklinikum Koln
RECRUITINGCologne, 50937, Germany
-
University of California, San Diego
RECRUITINGLa Jolla, California, 92037, United States
Conditions
Explore the condition pages connected to this study.